baber/WOPTO huggingface dataset:
Patent IL-69710-A0 (IL)
Title: Preparation of vinyl carbamates and certain such novel compounds
IPC: C07C271/12
Filed: 1983-09-13
Abstract: 1. Process for preparing vinyl carbamates of the formula I :  see diagramm : EP0104984,P29,F1  in which R1 and R2 , which may be identical or different, denote a hydrogen atom, or a substituted or unsubstituted, saturated or unsaturated aliphatic radical, or alternatively R1 and R2 , together with the carbon atom to which they are attached, form a ring which is saturated or unsaturated and substituted or unsubstituted, R3 and R4 are identical or different and denote a hydrogen atom, an aliphatic or cycloaliphatic radical, substituted or unsubstituted and saturated or unsaturated, the unsaturation occurring on a carbon atom which is not adjacent to the nitrogen atom, a radical or formula  see diagramm : EP0104984,P29,F2 in which Y is an alkyl radical, R1 and R2 are defined as above and Z is a hydrocarbon chain containing 2 to 20 carbon atoms, or Z is a hydrocarbon chain consisting of 2 to 20 carbon atoms and containing, in addition, hetero atoms W, W being O, S, NR", each hetero atom being separated from another hetero atom by at least two carbon atoms and R" being a hydrocarbon radical, or Z is a group  see diagramm : EP0104984,P29,F3  10, or a substituted or unsubstituted aromatic radical, or alternatively R3 and R4 form, together with the nitrogen atom to which they are attached, a substituted or unsubstituted, saturated or unsaturated heterocycle, R3 and R4 form, together with the nitrogen atom to which they are attached, a heterocycle which is part of a substituted or unsubstituted, saturated or unsaturated fused ring system, R3 and R4 form, together with the nitrogen atom to which they are attached, a heterocycle which contains at least one other hetero atom which is O, S, N or NRx , Rx being a hydrocarbon radical, and/or a nitrogen atom which forms a vinyl carbamate group, R3 and R4 form, together with the nitrogen atom to which they are attached, a ring of formula  see diagramm : EP0104984,P29,F4  in which Z, R1 and R2 have the above meaning, R3 and R4 form a piperazine ring together with the nitrogen atom to which they are attached, the two nitrogen atoms of the piperazine ring bearing the group of formula :  see diagramm : EP0104984,P29,F5  in which R1 and R2 have the above meaning, which consists in heating an alpha-halogenated carbamate of formula (II) :  see diagramm : EP0104984,P30,F1  in which R1 , R2 , R3 and R4 are defined as above and when, in the compound of formula (I), R3 and R4 denote a radical which contains a vinyl carbamate group, the latter is present in the compound of the formula (II) in the form of a saturated carbamate containing a hydrogen atom at the beta-position and X at the alpha-position, X is a halogen atom, at a temperature of between 80 degrees C and 200 degrees C for a period of between a few minutes and several hours.
Patent IL-73472-A0 (IL)
Title: Novel polypeptides with an alpha-amylase-inhibiting action,a process for their preparation,their use and pharmaceutical products
IPC: C12P21/04
Filed: 1984-11-09
Abstract: Cyclic polypeptides of the formula I    <IMAGE>  I  in which Z, S, Y and AS have the meanings given, a process for their preparation and their use are described. The compounds have an  alpha -amylase-inhibiting action.
Patent IL-78478-A0 (IL)
Title: Multizone analytical element having labeled reagent concentration zone
IPC: G01N33/543
Filed: 1986-04-11
Abstract: A multizone test device for the determination of analyte from a liquid test medium upon contact with the liquid test medium and a labeled reagent comprising a chemical group having a detectable chemical property. The test device preferably comprises multilayers including a reagent layer incorporated with an immobilized reagent and a detection layer incorporated with an immobilized form of an interactive detection reagent for the labeled reagent. The immobilized reagent and the labeled reagent comprise specific binding partners which will bind to each other dependent upon the amount of analyte present. Labeled reagent which does not become bound to the immobilized reagent in the reagent layer migrates into the detection layer and becomes bound to and immobilized by the immobilized binding substance therein. As a result, reverse migration of the labeled reagent into the reagent layer is prevented and the detectable physical property provided by the label of the labeled reagent is localized in the detection layer for the precise measurement thereof and correlation to the amount of analyte in the test medium.
Patent IL-84449-A0 (IL)
Title: Super conducting metal oxide complex
IPC: H01L39/12
Filed: 1987-11-12
Abstract: Described is a superconducting composition comprising an oxide complex of the formula [L1-xMx]aAbOy wherien L is scandium, yttrium, lanthanum, cerium, praseodymium, neodymium, samarium, europium, gadolinium, terbium, dysprosium, holmium, erbium, thulium, ytterbium, lutetium, or a combination thereof; "M" is barium, strontium, calcium, magnesium, mercury, or a combination thereof provided that when "L" is lanthanum "M" is not barium; "A" is copper, bismuth, titanium, tungsten, zirconium, tantalum, niobium, vanadium or a combination thereof "x" is from about 0.01 to about 1.0; "a" is 1 to 2; "b" is 1; and "y" is about 2 to about 4. The oxide complexes of the invention are prepared by a solid-state reaction procedure which produce oxide complexes having enhanced superconducting transition temperatures compared to an oxide complex of like empirical composition prepared by a co-precipitation - high temperature decomposition procedure. With a solid-state reaction prepared oxide complex of the invention a transition temperature as high as 100 DEG K has been observed even under atmospheric pressure. There is also disclosed a method for conducting an electrical current using an oxide complex described above as conductor material.
Patent IL-92374-A0 (IL)
Title: Skin test and test kit for aids
IPC: A61K49/00
Filed: 1989-11-20
Abstract: A method for the detection of AIDS virus infection in humans involves the introduction of an effective amount of an immunogenic AIDS virus envelope protein intradermally into a human and the subsequent observation of the injection site for an immune response, such as a characteristic redness or swelling.
Patent IL-94033-A0 (IL)
Title: Process for making oriented,shaped articles of lyotropic polysaccharide
IPC: D21H15/10
Filed: 1990-04-06
Abstract: Spinnable dopes containing fiber-forming polymers being at least about 55% and less than about 80% lyotropic polysaccharide and at least about 20 percent and less than about 45% thermally-consolidatable polymer and a process for making oriented, shaped articles of lyotropic polysaccharide/thermally-consolidatable polymer blends by orienting the dopes and removing the solvent.
Patent IL-99383-A0 (IL)
Title: Enzymatic process for the conversion of preproinsulins into insulins
IPC: C07K14/62
Filed: 1991-09-03
Abstract: A process for the specific hydrolysis of the amino-acid chain of preproinsulins to give the corresponding intermediates with the aid of clostripain is described, and these intermediates can be converted where appropriate with carboxypeptidase B into the corresponding insulins.
Patent IL-99471-A0 (IL)
Title: Pharmaceutical compositions containing pyridylmethylsulphinyl-1h-benzimidazole derivatives as active ingredient therein
IPC: A61K31/44
Filed: 1991-09-12
Abstract: The invention concerns the use of compound of formula (I), in which the substituents and symbols are as defined in the specification, against Helicobacter bacteria.
Patent IL-99868-A0 (IL)
Title: 2-(3-oxypyridinyl)-1,3-dioxolane and dioxane derivatives,fungicidal compositions containing the same and methods for controlling a fungus utilizing the same
IPC: C07D405/12
Filed: 1991-10-27
Abstract: A compound having the structural formula   <IMAGE>   where R and R1 are the same or different and are hydrogen or C1-C6 alkyl; R2 is hydrogen, chlorine or bromine; R3 is hydrogen, C1-C6 alkyl, C1-C6 alkoxy, halogen, trihalomethyl, nitro, cyano, phenyl, phenyl subsituted with C1-C4 alkyl, C1-C4 alkoxy, halogen, trihalomethyl, nitro or cyano, phenoxy or phenoxy subsituted with C1-C4 alkyl, C1-C4 alkoxy, halogen, trihalomethyl, nitro or cyano; and n is 0 or 1 is disclosed. A composition which comprises a fungicidally effective amount of the compound and a carrier therefor is also set forth. In addition, a process for controlling phytopathogenic fungi wherein a fungicidally effective amount of the compound is applied to the locus to be protected is described.
Patent FI-20011726-A0 (FI)
Inventor: PALTEMAA ILPO
IPC: H04W4/06
Filed: 2001-08-29
Abstract: In order to deliver monitoring information without a centralized server, a multicast router is introduced into a network. A group is generated (5-1, 5-2, 5-8, 5-11) for a mobile station to be monitored, the group including a multicast group address and monitors of the mobile station registered (5-11) as members of the group. Monitored event information is transmitted to the members of the group by utilising a multicast functionality.
Patent FI-20030937-A0 (FI)
Inventor: LEHTIKANGAS JUHA
IPC: H04W88/18
Filed: 2003-06-24
Abstract: The method involves transmitting a short message to a short message service center (SMSC) and a mobile switching center (MSC).The message is transmitted to a target number which depends on an A-subscriber and is a short number common to the A-subscriber. The short number is converted into a connection number and suitable for the communication network of a B-subscriber. An independent claim is also included for a system for transmitting short messages from an A-subscriber to a B-subscriber.
Patent FI-20110291-A0 (FI)
Inventor: OLIVER JAMES
IPC: C21C/
Filed: 2011-09-07
Abstract: The invention relates a duplex ferritic austenitic stainless steel having high formability utilizing the TRIP effect and high corrosion resistance with the balanced pitting resistance equivalent. The duplex stainless steel contains less than 0,04 weight % carbon, less than 0,7 weight % silicon, less than 2,5 weight % manganese, 18,5-22,5 weight % chromium, 0,8-4,5 weight % nickel, 0,6-1,4 weight % molybdenum, less than 1 weight % copper, 0,10-0,24 weight % nitrogen, the rest being iron and inevitable impurities occurring in stainless steels.
Patent FI-20115669-A0 (FI)
Inventor: ÅSTRÖM KIM
IPC: H02J/
Filed: 2011-06-23
Abstract: The object of the invention is an offset control arrangement for controlling voltage values in a fuel cell system for producing electricity with fuel cells, each fuel cell in the fuel cell system comprising an anode side (100), a cathode side (102) and an electrolyte (104) between the anode side and the cathode side, the fuel cell system comprising at least one fuel cell array (103) of at least two fuel cells, and at least one load (146) for performing load function. The offset control arrangement comprises voltage monitoring means (142) for monitoring input voltage of the load (146) to obtain monitoring information, a control processor (120) for processing said monitoring information, at least one offsetting source (140) in serial connection to the at least one fuel cell array (103), power level of the offsetting source (140) being substantially low compared to the power level of the fuel cell array (103), and the offsetting source (140) is being arranged to perform at least unidirectional shifting of fuel cell array output voltage to reduce voltage window apparent to the load (146) on the basis of at least one of the monitoring information and the processed monitoring information, and the offset control arrangement further comprises means (144) for disconnecting the at least one fuel cell array (103) from the load (146), when a reason for the disconnection is detected in the fuel cell system.
Patent IL-100120-A0 (IL)
Title: Pharmaceutical compositions containing sulfonamides,certain sulfonamides and process for their production
IPC: C07C311/17
Filed: 1991-11-21
Abstract: Anti-atherosclerotically effective medicaments containing a compound of formula (I) in which: R1? and R2?, which may be the same or different, are a hydrogen atom or a straight-chained or branched alkyl radical with 1 to 4 C atoms; A is a straight-chained or branched alkylene chain with 1 to 5 C atoms; X is a hydrogen atom or a C1?-C4?-alkyl radical, and Y is a straight-chained or branched alkyl radical with 1 to 5 C atoms, an aralkyl or aryl radical, whereby the aryl radical may be substituted singly to triply in all possible positions on the ring by halogen, trifluoromethyl, C1?-C4?-alkyl, amino, C1?-C4?-acylamino, di(C1?-C4?)-alkylamino or nitro; with the proviso that A may also signify valency if no Y signifies an aryl radical, and their pharmacologically acceptable salts, novel sulphonamides and process for producing them.
Patent IL-102806-A0 (IL)
Title: Therapeutic agents
IPC: C07D401/06
Filed: 1992-08-14
Abstract: Compounds of formula I, and pharmaceutically acceptable salts thereof, useful in the treatment of neuropsychisatric disoders such as psychoses; pharmaceutical compositions comprising a compound of formula I and a pharmaceutically acceptable diluent or carrier; and methods of treating neuropschiatric disorders comprising administering to a mammal (including man) in need of such treatment an effective amount of a compound of formula I, or a pharmaceutically acceptable salts thereof. <IMAGE>
Patent IL-107814-A0 (IL)
Title: Cloning and eypression of biologically active alphagalactosidase a
IPC: C12N15/56
Filed: 1993-11-30
Abstract: The present invention discloses a method for producing a secreted biologically active mature ±-galactosidase A that contains ±2,6-sialic acid residues, comprising culturing an engineered mammalian cell that expresses ±-galactoside ±2,6-sialyltransferase such that the cell is capable of peptide sialylation, wherein the cell further comprises a nucleotide sequence that regulates gene expression operatively associated with an ±-galactosidase A gene sequence under conditions in which the ±-galactosidase A is sufficiently overexpressed by the engineered mammalian cell so as to be selectively secreted into the mammalian cell culture as a biologically active mature ±-galactosidase A that contains ±2,6-sialic acid residues; and isolating biologically active mature ±-galactosidase A that contains ±2,6-sialic acid residues from the mammalian cell culture.
Patent IL-111996-A0 (IL)
Title: Enzymatic conversion of proteins using immobilized dictyostelium dipeptidylaminopeptidase
IPC: C12P21/06
Filed: 1994-12-15
Abstract: The present invention concerns a novel process for using a recently discovered dipeptidylaminopeptidase isolated from the cellular slime mold, Dictyostelium discoideum (dDAP). The claimed process involves immobilizing dDAP onto a support surface so that even numbered, N-terminal dipeptides can be efficiently removed from precursor proteins or polypeptides to yield desired processed proteins or polypeptides. The invention provides a means for reusing dDAP in multiple conversion reaction runs, as the enzyme does not become a part of the substrate/product solution. The claimed process is particularly useful for converting a precursor human proinsulin analog (Met-Arg-Human Proinsulin having Lys at position 28 and Pro at position 29 of the corresponding insulin B-chain; MR-KPB-hPI) to a processed insulin analog (Human Proinsulin having Lys at position 28 and Pro at position 29 of the corresponding insulin B-chain, KPB-hPI).
Patent IL-116065-A0 (IL)
Title: Azacyclic or azabicyclic compounds their preparation and pharmaceutical compositions containing them
IPC: A61P25/02
Filed: 1995-11-20
Abstract: The present invention relates to therapeutically active azacyclic or azabicyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating diseases in the central nervous system caused by malfunctioning of the muscarinic cholinergic system.
Patent IL-117405-A0 (IL)
Title: Stable transglutaminase preparations and processes for producing them
IPC: A61K9/14
Filed: 1996-03-07
Abstract: Stable compsn. contg. a transglutaminase (I) which is readily soluble without turbidity after freeze drying comprises: purified (I) and as stabiliser D- and/or L-amino acids (or their salts, derivs., homologues, dimers, oligomers or mixt.), and/or sugar or sugar alcohol, opt. together with surfactants and/or reducing agents, excluding glycine and arginine.
Patent IL-118150-A0 (IL)
Title: Isolating and culturing schwann cells
IPC: A61K35/12
Filed: 1996-05-05
Abstract: A method for enhancing the survival and/or proliferation of Schwann cells (especially human Schwann cells) in cell culture is disclosed which involves culturing the cells in serum free culture medium comprising gas6 and other mitogenic agents, such as heregulin and forskolin. The culturing step is generally preceded by a pre-incubation period wherein nerve tissue comprising the Schwann cells is cultured under appropriate conditions and for a period of time such that demyelination occurs. The isolated Schwann cells can be used as cellular prostheses to treat patients with nervous system injuries. The invention also provides a cell culture medium for culturing Schwann cells.
Patent IL-119911-A0 (IL)
Title: Surgical clip
Inventor: MONASSEVITCH LEONID
IPC: A61B17/00
Filed: 1996-12-25
Abstract: This invention is a surgical clip (10) including three lengths of wire integrally formed of a shape memory alloy, two of which (12, 22) each form closed geometrical shapes similar in configuration and magnitude to each other, and the third (18) connects the first two. When at a first temperature or higher, the first and second lengths of wire (12, 22) are positioned in a side by side closed position. The shape memory alloy is in an elastic sate. When at a second temperature or lower, below the first temperature, the shape memory alloy is in a plastic state, thereby enabling the first and second lengths of wire (12, 22) to be moved into and to retain a spaced apart position. Upon heating of the clip to a temperature at least equal to the first temperature, the first and second lengths of wire return to the side by side closed position, thereby to apply a compressive force to tissue located therebetween; and a method of anastomosing a gastrointestinal tract with such a surgical clip (10).
Patent IL-130630-A0 (IL)
Title: Optical array converting UV
IPC: G01J1/02
Filed: 1997-12-29
Abstract: An optical array containing a system of absorptive filters and a system of interference filters. For the sun light the spectral characteristics of transmission of the optical array is close to the world-wide accepted Diffey Standard. That standard models human skin sensitivity to UV burning. The invention allows making inexpensive, miniature UV sensors that can be applied in a miniature devices measuring burning power of UV contained in the sun light.
Patent IL-134153-A0 (IL)
Title: Panel-shaped material
IPC: A47B96/20
Filed: 1998-07-16
Abstract: The invention relates to a panel-shaped material, for use especially as a kitchen work top, table top or such like, comprising a panel-shaped support, a covering layer joined to the panel-shaped support across the surface thereof and a covering element which is arranged along at least one side edge of said support and joined to the covering layer in a monobloc manner. To be able to produce in an economical manner a material of this kind which remains stable even in a humid environment the invention provides for the support to have a covering layer on one side only, for the covering layer and covering element to be made of a plastic material filled with an inorganic filler and for the covering layer to have a thickness ranging between 3 and 10 mm and to be joined to the support by means of a hardenable resin across its entire surface and substantially without the formation of bubbles.
Patent IL-145607-A0 (IL)
Title: Diagnostic sequencing by a combination of specific cleavage and mass spectrometry
IPC: G01N33/566
Filed: 2000-04-30
Abstract: The present invention is in the field of nucleic acid-based diagnostic assays. More particularly, it relates to methods useful for the "diagnostic sequencing" of regions of sample nucleic acids for which a prototypic or reference sequence is already available (also referred to as "re-sequencing"), or which may be determined using the methods described herein. This diagnostic technology is useful in areas that require such re-sequencing in a rapid and reliable way: (i) the identification of the various allelic sequences of a certain region/gene, (ii) the scoring of disease-associated mutations, (iii) the detection of somatic variations, (iv) studies in the field of molecular evolution, (v) the determination of the nucleic acid sequences of prokaryotic and eukaryotic genomes; (vi) identifying one or more nucleic acids in one or more biological samples; (vii) and determining the expression profile of genes in a biological sample and other areas.
Patent IL-146221-A0 (IL)
Title: NOVEL INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-α MODULATORS, SYNTHESES OF SAID MODULATORS AND METHODS OF USING SAID MODULATORS
IPC: A61K31/215
Filed: 2000-05-12
Abstract: A compound having the following chemical structure:   
its produg esters and acid-addition salts, useful as Interleukin-1 and Tumor Necrosis Factor-± modulators, wherein R groups are defined in the claims.
Patent IL-149285-A0 (IL)
Title: Di-triazole enantiomeric compounds serving as intermediates for the preparation of antifungal azoles
IPC: A61K31/496
Filed: 2002-04-23
Abstract: The present invention concerns novel compounds of formulathe N-oxide forms, the pharmaceutically acceptable addition salts thereof and stereochemically isomeric forms thereof, wherein -A-B- forms a bivalent radical of formula -N=CH- (a), -CH=N- (b), -CH=CH- (c), L represents the acyl moiety of an amino acid; D is an azole containing 1,3- or 1,4-dioxolane derivative as broad-spectrum antifungals; their preparation, compositions containing them and their use as a medicine.
Patent IL-157279-A0 (IL)
Title: Refractory metal plates with uniform texture and methods of making the same
IPC: C22F1/18
Filed: 2002-02-20
Abstract: A method (10) of forming sputtering target (11) from ingots of tantalum or niobium of requisite purity by the process of cutting the ingot to short lengths (12) and pressure working (14, 22, 30, 34) the ingot along alternating essentially orthogonal work axes. Intermediate anneals (18, 26, 38) are applied as necessary to establish a uniform texture thickness-wise and area-wide throughout the target, including the center. The uniform texture is a substantially constant mix of grains with orientation {100} and {111}, thereby improving sputtering performance by providing a more predictable sputter rate to control film thickness.
Patent IL-160172-A0 (IL)
Title: Printing cartridge with barcode identification
IPC: B41J2/16
Filed: 2002-07-09
Abstract: A printing cartridge includes a roll of print media; a tubular former around which the roll of print media is wound, the tubular former being internally separated into two or more sections along a longitudinal axis of the tubular former and adapted to store supplies of fluid therein; a casing comprising a pair of molded covers, the pair of molded covers being configured to releasably fasten together to encase the roll of print media; and an ink collar for sealing an end of the tubular former, the ink collar defining two or more slits adapted to receive therethrough fluid communication pins, whereby access to the supplies of fluid in the tubular former is effected.